Report Summary
Eternity Insights has published a new study on Global Human Microbiome Market focusing on key segments as By Product (Probiotics, Prebiotics, Diagnostic Tests, Drugs, Other), By Disease (Infectious Diseases, Endocrine and Metabolic Disorders, Gastrointestinal Diseases, Cancer, Other), By Application (Therapeutics, Diagnostics), By Type (FMT, Peptide, Live Biotherapeutic Product, Others), By Technology (Genomics, Proteomics, Metabolomics), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Human Microbiome Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Human Microbiome Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Human Microbiome Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Human Microbiome Market Segmentation:
Human Microbiome Market, By Product
- Probiotics
- Prebiotics
- Diagnostic Tests
- Drugs
- Other Products
Human Microbiome Market, By Disease
- Infectious Diseases
- Endocrine and Metabolic Disorders
- Gastrointestinal Diseases
- Cancer
- Other Diseases (cardiovascular diseases, neurological disorders, dermatology diseases, immune-modulated disorders, and hematological disorders.
Human Microbiome Market, By Application
Human Microbiome Market, By Type
- FMT
- Peptide
- Live Biotherapeutic Product
- Others
Human Microbiome Market, By Technology
- Genomics
- Sequencing
- 16s rRNA sequencing method
- Whole-genome sequencing method
- Other Sequencing methods (shotgun metagenomic sequencing, transcriptomics, and targeted sequencing.)
- Other Genomic Technologies (Polymerase Chain Reaction (PCR), Fluorescence In Situ Hybridization (FISH), and DNA Microarrays)
- Proteomics
- Metabolomics
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Human Microbiome market in terms of demand generation. The Human Microbiome market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Human Microbiome market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Human Microbiome Market Taxonomy:
To learn more about this report
Global Human Microbiome Market Competitive Landscape
The global Human Microbiome market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Second Genome
- Enterome Bioscience
- Yakult
- DuPont
- Vedanta BioSciences
- Metabiomics Corporation
- ViThera Pharmaceuticals
- MicroBiome Therapeutics
- Osel
- Merck
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
FMT, Peptide, Live Biotherapeutic Product, Others |
| By Application Outlook |
Therapeutics, Diagnostics |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Second Genome,Enterome Bioscience,Yakult,DuPont,Vedanta BioSciences,Metabiomics Corporation,ViThera Pharmaceuticals,MicroBiome Therapeutics,Osel,Merck |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stakeholders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Human Microbiome Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Human Microbiome Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Human Microbiome Industry Overview
2.1 Global Human Microbiome Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Human Microbiome Global Import Market Analysis
2.1.2 Human Microbiome Global Export Market Analysis
2.1.3 Human Microbiome Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Therapeutics
2.2.2 Diagnostics
2.3.2 Hospital
2.3.3 Surgical Centers
2.3.4 Others
2.4.2 Global Human Microbiome Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Human Microbiome Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Human Microbiome Manufacturer Market Share
2.4.5 Top 10 Human Microbiome Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Human Microbiome Market
2.4.7 Key Manufacturers Human Microbiome Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Human Microbiome Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Human Microbiome Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Human Microbiome Market Size Categorized by Regions
4.1 Global Human Microbiome Revenue, Sales and Market Share by Regions
4.1.1 Global Human Microbiome Sales and Market Share by Regions (2015-2020)
4.1.2 Global Human Microbiome Revenue and Market Share by Regions (2015-2020)
4.2 Europe Human Microbiome Sales and Growth Rate (2015-2020)
4.3 APAC Human Microbiome Sales and Growth Rate (2015-2020)
4.4 North America Human Microbiome Sales and Growth Rate (2015-2020)
4.5 South America Human Microbiome Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Human Microbiome Sales and Growth Rate (2015-2020)
5 Europe Human Microbiome Market Size Categorized by Countries
5.1 Europe Human Microbiome Sales, Revenue and Market Share by Countries
5.1.1 Europe Human Microbiome Sales by Countries (2015-2020)
5.1.2 Europe Human Microbiome Revenue by Countries (2015-2020)
5.1.3 Germany Human Microbiome Sales and Growth Rate (2015-2020)
5.1.4 UK Human Microbiome Sales and Growth Rate (2015-2020)
5.1.5 France Human Microbiome Sales and Growth Rate (2015-2020)
5.1.6 Russia Human Microbiome Sales and Growth Rate (2015-2020)
5.1.7 Italy Human Microbiome Sales and Growth Rate (2015-2020)
5.1.8 Spain Human Microbiome Sales and Growth Rate (2015-2020)
5.2 Europe Human Microbiome Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Human Microbiome Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Human Microbiome Sales Market Share by Type (2015-2020)
5.3.2 Europe Human Microbiome Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Human Microbiome Sales Market Share by Application (2015-2020)
6 Asia-Pacific Human Microbiome Market Size Categorized by Countries
6.1 Asia-Pacific Human Microbiome Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Human Microbiome Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Human Microbiome Revenue by Countries (2015-2020)
6.1.3 China Human Microbiome Sales and Growth Rate (2015-2020)
6.1.4 Japan Human Microbiome Sales and Growth Rate (2015-2020)
6.1.5 Korea Human Microbiome Sales and Growth Rate (2015-2020)
6.1.6 India Human Microbiome Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Human Microbiome Sales and Growth Rate (2015-2020)
6.1.8 Australia Human Microbiome Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Human Microbiome Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Human Microbiome Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Human Microbiome Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Human Microbiome Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Human Microbiome Sales and Market Share by Application (2015-2020)
7 North America Human Microbiome Market Size Categorized by Countries
7.1 North America Human Microbiome Sales, Revenue and Market Share by Countries
7.1.1 North America Human Microbiome Sales by Countries (2015-2020)
7.1.2 North America Human Microbiome Revenue by Countries (2015-2020)
7.1.3 United States Human Microbiome Sales and Growth Rate (2015-2020)
7.1.4 Canada Human Microbiome Sales and Growth Rate (2015-2020)
7.1.5 Mexico Human Microbiome Sales and Growth Rate (2015-2020)
7.2 North America Human Microbiome Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Human Microbiome Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Human Microbiome Sales Market Share by Type (2015-2020)
7.3.2 North America Human Microbiome Revenue and Revenue Share by Type (2015-2020)
7.4 North America Human Microbiome Sales Market Share by Application (2015-2020)
8 South America Human Microbiome Market Size Categorized by Countries
8.1 South America Human Microbiome Sales, Revenue and Market Share by Countries
8.1.1 South America Human Microbiome Sales by Countries (2015-2020)
8.1.2 South America Human Microbiome Revenue by Countries (2015-2020)
8.1.3 Brazil Human Microbiome Sales and Growth Rate (2015-2020)
8.2 South America Human Microbiome Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Human Microbiome Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Human Microbiome Sales Market Share by Type (2015-2020)
8.3.2 South America Human Microbiome Revenue and Revenue Share by Type (2015-2020)
8.4 South America Human Microbiome Sales Market Share by Application (2015-2020)
9 Middle East and Africa Human Microbiome Market Size Categorized by Countries
9.1 Middle East and Africa Human Microbiome Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Human Microbiome Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Human Microbiome Revenue by Countries (2015-2020)
9.1.3 GCC Countries Human Microbiome Sales and Growth Rate (2015-2020)
9.1.4 Turkey Human Microbiome Sales and Growth Rate (2015-2020)
9.1.5 Egypt Human Microbiome Sales and Growth Rate (2015-2020)
9.1.6 South Africa Human Microbiome Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Human Microbiome Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Human Microbiome Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Human Microbiome Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Human Microbiome Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Human Microbiome Sales Market Share by Application (2015-2020)
10 Global Human Microbiome Market Segment by Type
10.1 Global Human Microbiome Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Human Microbiome Sales and Market Share by Type (2015-2020)
10.1.2 Global Human Microbiome Revenue and Market Share by Type (2015-2020)
10.2 Therapeutics Sales Growth Rate and Price
10.2.1 Global Therapeutics Sales Growth Rate (2015-2020)
10.2.2 Global Therapeutics Price (2015-2020)
10.3 Diagnostics Sales Growth Rate and Price
10.3.1 Global Diagnostics Sales Growth Rate (2015-2020)
10.3.2 Global Diagnostics Price (2015-2020)
11.1 Global Human MicrobiomeSales Market Share by Application (2015-2020)
11.2 Clinical Research Institutes Sales Growth Rate (2015-2020)
11.3 Hospital Sales Growth Rate (2015-2020)
11.4 Surgical Centers Sales Growth Rate (2015-2020)
11.5 Others Sales Growth Rate (2015-2020)
12.1 Global Human Microbiome Revenue, Sales and Growth Rate (2020-2027)
12.2 Human Microbiome Market Forecast by Regions (2020-2027)
12.2.1 Europe Human Microbiome Market Forecast (2020-2027)
12.2.2 APAC Human Microbiome Market Forecast (2020-2027)
12.2.3 North America Human Microbiome Market Forecast (2020-2027)
12.2.4 South America Human Microbiome Market Forecast (2020-2027)
12.2.5 Middle East & Africa Human Microbiome Market Forecast (2020-2027)
12.3 Human Microbiome Market Forecast by Type (2020-2027)
12.3.1 Global Human Microbiome Sales Forecast by Type (2020-2027)
12.3.2 Global Human Microbiome Market Share Forecast by Type (2020-2027)
12.4 Human Microbiome Market Forecast by Application (2020-2027)
12.4.1 Global Human Microbiome Sales Forecast by Application (2020-2027)
12.4.2 Global Human Microbiome Market Share Forecast by Application (2020-2027)
13 Analysis of Human Microbiome Industry Key Manufacturers
13.1 Second Genome
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Second Genome Human Microbiome Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Second Genome News
13.2 Enterome Bioscience
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Enterome Bioscience Human Microbiome Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Enterome Bioscience News
13.3 Yakult
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Yakult Human Microbiome Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Yakult News
13.4 DuPont
13.4.1 Company Details
13.4.2 Product Information
13.4.3 DuPont Human Microbiome Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 DuPont News
13.5 Vedanta BioSciences
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Vedanta BioSciences Human Microbiome Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Vedanta BioSciences News
13.6 Metabiomics Corporation
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Metabiomics Corporation Human Microbiome Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Metabiomics Corporation News
13.7 ViThera Pharmaceuticals
13.7.1 Company Details
13.7.2 Product Information
13.7.3 ViThera Pharmaceuticals Human Microbiome Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 ViThera Pharmaceuticals News
13.8 MicroBiome Therapeutics
13.8.1 Company Details
13.8.2 Product Information
13.8.3 MicroBiome Therapeutics Human Microbiome Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 MicroBiome Therapeutics News
13.9 Osel
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Osel Human Microbiome Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Osel News
13.10 Merck
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Merck Human Microbiome Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Merck News
15 Appendix
